Cognitive Diagnostics Market is Likely to Witness Steady Growth by 2033

According to Future Market Insights' newest industry report, the global Cognitive Diagnostics market sales are expected to reach US$ 110.2 Billion in 2023, with a CAGR of 8.0% over the forecast period, reaching an estimated worth of US$ 238.3 Billion by 2033.

Closed head injuries, interaction with neurotoxins (toxic substances), heredity, infections, strokes, and tumours are all potential causes of brain difficulties or cognitive issues. A person may have a certain type of cognitive issue depending on the part of the brain that is afflicted. A cancer in the brain's speech cisterns, for example, could cause communication problems. In another example, a brain infection that damages the motor recentres would create movement issues. The development of cognitive difficulties is also influenced by age.

Wearables and smartphone apps are increasingly being used in cognitive diagnostics. These gadgets can monitor a patient's cognitive health and provide real-time information to medical workers for more precise diagnosis and management.

Collaboration and collaborations between academic institutions, technological enterprises, and healthcare providers are increasing in the market for cognitive diagnostics. These collaborations can encourage creativity, give access to technology and methodologies for diagnosing cognitive impairments, and accelerate the development of novel treatments for these conditions. For example, the Davos Alzheimer's Collaborative awarded Avant Institute, in collaboration with COGNIVUE, a grant in June 2022 to establish an innovative early-detection programme for Alzheimer's disease.

Key Players

  • Cognetivity Neurosciences
  • Cognivue, Inc.
  • Cogstate Ltd.
  • Cambridge Cognition Ltd.
  • Diadem srl
  • CN Diagnostics

Get More Insights@ https://www.futuremarketinsights.com/reports/cognitive-diagnostics-market

Key Market Segments Covered in the Cognitive Diagnostics Industry Research

Diagnosis:

  • Brain Imaging Tests
    • Magnetic Resonance Imaging (MRI)
    • Computerized Tomography (CT)
    • Positron Emission Tomography (PET) and PET/CT
  • Laboratory Testing
    • Cerebrospinal fluid (CSF)
    • Blood Tests
  • Mental Status Testing
    • Mini-Mental State Exam (MMSE)
    • Montreal Cognitive Assessment (MoCA)
  • Rapid Home Screening Tests
  • Neuropsychological Testing
  • Electroencephalogram (EEG)
  • Cognitive Function & Behavioral Tests
  • Neuropsychiatric Inventory Questionnaire (NPI-Q)

Indication:

  • Alzheimer’s disease
  • Attention deficit/hyperactivity disorder
  • Dementia
  • Epilepsy-Related Cognitive Dysfunction
  • Mild Cognitive Impairment
  • Parkinson’s Disease-related Cognitive Dysfunction
  • Stroke-related Cognitive Dysfunction
  • Traumatic Brain Injury
  • Others

End User:

  • Hospitals
  • Neurology Clinics
  • Cognitive Behavioral Therapy Centers
  • Rehabilitation Centers
  • Academic and Research Institutes
  • Diagnostic Imaging Centers
  • Home Care Settings

Comments

Post a Comment

Popular posts from this blog

Empowering Diabetics | A Comprehensive Analysis of the Continuous Glucose Monitoring Device Market

Image
According to Future Market Insights' recently released Continuous Glucose Monitoring Device Market Analysis report, global sales of Continuous Glucose Monitoring Device Market in 2022 will be US$ 4.9 Billion. The market is expected to be valued US$ 16.8 billion by 2033, with a CAGR of 11.9% from 2023 to 2033. Market growth is predicted to be driven by an increase in the older population as well as a high prevalence of diabetes. The International Diabetes Federation predicts that the global diabetic population will reach 642 million by 2040. As a result, by 2040, one out of every 10 people would have diabetes, demonstrating the seriousness of the epidemic. Diabetes treatment and management are consequently projected to be a top priority for healthcare administrations and stakeholders around the world. Diabetes cases are predicted to increase, boosting market growth and the potential for continuous glucose monitoring systems, attracting and motivating various industry actors to prod...
Read more

Global Medical face shield Market Insights and Outlook 2022-2032

Image
Medical face shield can become as ubiquitous as masks, as new findings on the airborne spread of Covid-19 influence behavior and guidelines. According to a latest study by Future Market Insights,  Medical Face Shields Market  will grow at over 11% CAGR through 2030. Medical face shields have proven to be an effective first-line defence against airborne diseases such as Zika, SARS, Ebola, flu, and now Covid-19. As a result, increased adoption of medical face shields, and thus increased production, is expected to drive the market during the forecast period. The IDSA (Infectious Diseases Society of America) has included the use of PPE (Personal Protective Equipment) such as face shields and masks in its recommendations. Though masks have been widely used throughout the world, their effectiveness is not widely known. The possibility of cloth masks providing marginal virus protection due to potential moisture retention, poor filtration, and re-use cannot be ruled out. Face ...
Read more

Cognitive Diagnostics Market Projected to Reach Unprecedented Growth by 2033

Image
As per Future Market Insights latest industry analysis, the valuation for the global  Cognitive Diagnostics market sales  is estimated to reach US$ 110.2 Billion in 2023 and is projected to exhibit a CAGR of 8.0% over the forecast period, with an estimated valuation of US$ 238.3 Billion by 2033. Several causes of brain problems or cognitive disorders include closed head injuries, contact with neurotoxins (toxic substances), genetics, infections, strokes, and tumours. Depending on the area of the brain that is impacted, a person may have a certain form of cognitive problem. Communication issues could result from, for instance, a tumour in the speech cisterns of the brain. In another illustration, a brain infection that affects the motor recentres would cause problems with movement. Ageing is also a factor in the development of cognitive problems. Cognitive diagnostics increasingly use digital health technologies like wearables and smartphone apps. These tools can monitor a pati...
Read more